CareDx Inc reports results for the quarter ended in December - Earnings Summary

CareDx

28/02/2024 23:50

* CareDx Inc  CDNA.OQ  reported a quarterly adjusted loss
of 17
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -7
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 27 cents per share. Wall Street expected
results to range from -29 cents to -24 cents per share.
    * Revenue fell 20.4% to $65.57 million from a year ago;
analysts
expected $63.66 million. 
    * CareDx Inc's reported EPS for the quarter was a loss of
$2.21​.
    * The company reported a quarterly loss of $118.1 million.
    * CareDx Inc shares had fallen by 20.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5% in
the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CareDx Inc is
$12.00 
This summary was machine generated from LSEG data February 28 at
11:50 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.27          -0.17          Beat
 Sep. 30 2023      -0.40          -0.18          Beat
 Jun. 30 2023      -0.31          -0.18          Beat
 Mar. 31 2023      -0.11          -0.11          Met